Mohit Burman, the youngest among the newly appointed corporate heads among Dabur businesses, is known to have a penchant for acquisitions.
CCI is India's competition regulator. The undertaking will be a part of the CCI's proposed 'competition compliance' programme.
Interestingly, the allegations against Indian arm of the world's largest pharma maker also relates to its acquisition of the Indian subsidiary of Parke Davis by Pfizer in 2000.
Among the companies that have shown interest in NTC are Abhishek Industries, Alps Industries, Falcon Tyres, Alok Industries and Nitco.
Individual scientists attached to research institutions and domestic companies like Lupin, Dr Reddy's and Cadila account for the rest.
Drug banks, cancer fund now health ministry's babies.
Indian companies are unable to raise prices because 35 per cent of the drugs sold in the country come under the government's price control order.
With financial results for the quarter round the corner, small- and medium-sized, export-oriented pharmaceutical companies are expecting a 5-10 per cent decline in their bottom line for the April-June period, owing to the rupee appreciation.
The government is likely to accord special economic zone status to the proposed mega food parks that come up during the 11th Five-Year Plan (2007-12).
All directors on the board of companies will mandatorily need a director identification number from July 1. The number is also mandatory for e-filing of various returns and documents.
A decline in exports, which is a distinct possibility at the moment, would affect employment in the sector and even lead to a loss of existing jobs.
Another user of the data is the clinical diabetics' consortium, which aims to identify if there are specific genetic reasons for a particular ethnic group to be predisposed to the disease.
The move is in line with the NPPA's recent policy of putting a cap on prices.
The hospital has ordered a new cath-lab and is readying its entire idle capacities to make room for Trehan's surgeons.
To give a new thrust to the National Highway Development Programme, the government has decided to pump in Rs 20,000 crore (Rs 200 billion) for six-laning of 3,000 km highways under phase-V of the programme in 2007-08.
In April, Mumbai-based pharmaceutical company Wockhardt announced it had received five marketing approvals for its generic medicines, versions of those that have gone off patents, from the US Food and Drug Administration in five weeks.
Ranbaxy earned $114 million from its US operations in 2006. It launched 10 new products during the year. The company said that the revenues from the sale of the newly acquired brands would be reflected from the next quarter.
Shivinder's dream project, of course, is the Medicity he wants to put up at Gurgaon on the outskirts of New Delhi. That is where the problem with Trehan began, who has his own plans to come up with a similar project at Gurgaon.
Following hectic negotiations, Fortis Healthcare managing director Shivinder Singh and Naresh Trehan have finally smoked the peace pipe
After making big-ticket acquisitions abroad, leading Indian pharmaceutical companies like Dr Reddy's Laboratories, Ranbaxy Laboratories, and Aurobindo Pharma are rapidly shifting production to their Indian facilities.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances